SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 11-K
(mark one) |
|
|
x |
|
ANNUAL REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the fiscal year ended April 30, 2007
Or
o |
|
TRANSITION REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
Commission File No.: 1-7707
A. |
|
Full title of the plan and the address of the plan, if different from that of the issuer named below: |
THE MEDTRONIC PUERTO RICO
EMPLOYEES SAVINGS AND INVESTMENT PLAN
B. |
|
Name of issuer of the securities held pursuant to the plan and the address of its principal executive office: |
Medtronic, Inc.
710 Medtronic Parkway
Minneapolis, MN 55432
Required Information
1. |
The Medtronic Puerto Rico Employees Savings and Investment Plan Financial Statements and Supplemental Schedule April 30, 2007 and 2006 |
2. |
Exhibit 23 |
|
Consent of Independent Registered Public Accounting Firm |
SIGNATURES
The Plan. Pursuant to the requirements of the Securities Exchange Act of 1934, the trustees (or other persons who administer the employee benefit plan) have duly caused this annual report to be signed on its behalf by the undersigned hereunto duly authorized.
|
THE MEDTRONIC PUERTO RICO EMPLOYEES | |
|
|
|
Dated: October 24, 2007 |
By: |
/s/ Carol A. McCormick |
|
|
Carol A. McCormick |
The Medtronic Puerto Rico Employees Savings and Investment Plan
Financial Statements and Supplemental Schedule
April 30, 2007 and 2006
2
The Medtronic Puerto Rico Employees Savings and Investment Plan
Index to Financial Statements
|
|
|
|
Report of Independent Registered Public Accounting Firm |
|
|
|
Financial Statements: |
|
Statements of Assets Available for Benefits at April 30, 2007 and 2006 |
|
Statements of Changes in Assets Available for Benefits for the years ended April 30, 2007 and 2006 |
|
Notes to Financial Statements April 30, 2007 and 2006 |
|
|
|
Supplemental Schedule: |
|
Schedule H, Line 4i Schedule of Assets (Held at End of Year) at April 30, 2007 |
|
|
|
Note: |
|
Other schedules required by 29 CFR Section 2520.103-10 of the Department of Labors Rules and Regulations for Reporting and Disclosure under the Employee Retirement Income Security Act of 1974 have been omitted because they are not applicable. |
3
Report of Independent Registered Public Accounting Firm
To the Participants and Administrator of
The Medtronic Puerto Rico Employees Savings and Investment Plan:
In our opinion, the accompanying statements of assets available for benefits and the related statements of changes in assets available for benefits present fairly, in all material respects, the assets available for benefits of The Medtronic Puerto Rico Employees Savings and Investment Plan (the Plan) at April 30, 2007 and 2006, and the changes in assets available for benefits for the years then ended in conformity with accounting principles generally accepted in the United States of America. These financial statements are the responsibility of the Plans management. Our responsibility is to express an opinion on these financial statements based on our audits. We conducted our audits of these statements in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements, assessing the accounting principles used and significant estimates made by management, and evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.
Our audits were conducted for the purpose of forming an opinion on the basic financial statements taken as a whole. The supplemental schedule of Assets (Held at End of Year) as of April 30, 2007 is presented for the purpose of additional analysis and is not a required part of the basic financial statements but is supplementary information required by the Department of Labors Rules and Regulations for Reporting and Disclosure under the Employee Retirement Income Security Act of 1974. The supplemental schedule is the responsibility of the Plans management. The supplemental schedule has been subjected to the auditing procedures applied in the audits of the basic financial statements and, in our opinion, is fairly stated in all material respects in relation to the basic financial statements taken as a whole.
As discussed in Note 1, The Medtronic Puerto Rico Retirement Plan was merged into the Plan on June 1, 2006.
As discussed in Note 2, effective April 30, 2007, the Plan adopted FASB Staff Position Nos. AAG INV-1 and SOP 94-4-1, Reporting of Fully Benefit-Responsive Investment Contracts Held by Certain Investment Companies Subject to the AICPA Investment Company Guide and Defined-Contribution Health and Welfare and Pension Plans.
/s/ PricewaterhouseCoopers LLP
Minneapolis, Minnesota
October 12, 2007
4
The Medtronic Puerto Rico Employees Savings and Investment Plan
Statements of Assets Available for Benefits
(in 000s)
|
|
April 30, |
| ||||
|
|
2007 |
|
2006 |
| ||
|
|
|
|
|
|
|
|
Investments at fair value: |
|
|
|
|
|
|
|
Plans interest in the Medtronic, Inc. Master Trust Fund, at fair value (See Note 3) |
|
$ |
23,393 |
|
$ |
7,939 |
|
Mutual funds |
|
|
11,119 |
|
|
6,419 |
|
Participant loans receivable |
|
|
1,183 |
|
|
958 |
|
Total investments |
|
|
35,695 |
|
|
15,316 |
|
|
|
|
|
|
|
|
|
Contributions receivable: |
|
|
|
|
|
|
|
Employer |
|
|
277 |
|
|
20 |
|
Participant |
|
|
92 |
|
|
57 |
|
Total receivables |
|
|
369 |
|
|
77 |
|
Assets available for benefits at fair value |
|
|
36,064 |
|
|
15,393 |
|
Adjustment from fair value to contract value for Plans interest in the Medtronic, Inc. Master Trust Fund relating to fully benefit-responsive investment contracts (See Note 2) |
|
|
398 |
|
|
181 |
|
Assets available for benefits |
|
$ |
36,462 |
|
$ |
15,574 |
|
See accompanying notes to the financial statements.
5
The Medtronic Puerto Rico Employees Savings and Investment Plan
Statements of Changes in Assets Available for Benefits
(in 000s)
|
|
Years Ended April 30, |
| ||||
|
|
2007 |
|
2006 |
| ||
Investment income: |
|
|
|
|
|
|
|
Net appreciation in fair value of mutual funds |
|
$ |
688 |
|
$ |
537 |
|
Plans interest in the Medtronic, Inc. Master Trust Fund income |
|
|
979 |
|
|
130 |
|
Interest and dividends from investments |
|
|
383 |
|
|
200 |
|
Interest from participant loans |
|
|
69 |
|
|
44 |
|
Total investment income |
|
|
2,119 |
|
|
911 |
|
Contributions: |
|
|
|
|
|
|
|
Participant |
|
|
2,666 |
|
|
1,675 |
|
Employer |
|
|
4,221 |
|
|
645 |
|
Total contributions |
|
|
6,887 |
|
|
2,320 |
|
|
|
|
|
|
|
|
|
Transfer from other plan (Note 1) |
|
|
14,511 |
|
|
|
|
|
|
|
|
|
|
|
|
Deductions: |
|
|
|
|
|
|
|
Benefits paid to participants |
|
|
2,628 |
|
|
835 |
|
Administrative expenses |
|
|
1 |
|
|
1 |
|
Total deductions |
|
|
2,629 |
|
|
836 |
|
|
|
|
|
|
|
|
|
Net increase |
|
|
20,888 |
|
|
2,395 |
|
Assets available for benefits: |
|
|
|
|
|
|
|
Beginning of year |
|
|
15,574 |
|
|
13,179 |
|
End of year |
|
$ |
36,462 |
|
$ |
15,574 |
|
See accompanying notes to the financial statements.
6
The Medtronic Puerto Rico Employees Savings and Investment Plan
Notes to Financial Statements
1. |
Description of the Plan |
The following description of The Medtronic Puerto Rico Employees Savings and Investment Plan (the Plan) provides only general information. Participants should refer to the Plan document for a complete description of the Plans provisions.
Effective June 1, 2006, the Plan was amended and restated as a result of the merger of The Medtronic Puerto Rico Retirement Plan (the Retirement Plan) with the Plan.
|
Plan Merger and Transfer of Plan Assets |
On June 1, 2006, the Retirement Plan was merged into the Plan. In conjunction with the merger, the net assets of the Retirement Plan were transferred into the Plan resulting in an asset transfer in of $14,511,000.
Participants accounts in the Retirement Plan were transferred into a separate account in the Plan. Employer contributions made to the Retirement Plan during May 2006 were transferred to participants separate accounts in the Plan and on June 1, 2006, the Retirement Plan was merged with the Plan. All participant rights under the Retirement Plan apply to the transferred balance and amounts remain 100% vested.
General and Eligibility
The Plan is a contributory defined contribution plan created by Medtronic, Inc. (the Parent Company). Generally, the Plan covers all regular full-time and part-time employees of Medtronic Puerto Rico Operations Company Puerto Rico Branch (the Company). Prior to January 1, 2006, employees with at least three months of service were eligible to participate in the Plan. Employees hired on or after January 1, 2006 are eligible upon hire. Prior to May 1, 2006, employees were eligible to receive contributions in the Retirement Plan account after completing two years of service. Effective May 1, 2006, employees are eligible to receive contributions in the Retirement Plan account after completing one year of service. The Plan is subject to the provisions of the Employee Retirement Income Security Act of 1974, as amended (ERISA).
|
Administration of Plan Assets |
The Qualified Plan Committee (the Committee) of the Parent Company oversees the administration of the Plan. The Committee appointed Banco Popular de Puerto Rico (the Trustee) as Trustee of the Plan assets. Transactions are executed by the Trustee of the Plan, as directed by the Committee in its capacity as Plan Administrator. Vanguard Fiduciary Trust Company (Vanguard Trust) has been appointed as Recordkeeper for the Plan and to provide participant services, education and communication services. Vanguard Trust maintains a separate account in the name of each participant in the Plan to record the assets allocated to the participant and the earnings and losses thereon, and an allocation of administrative expenses.
|
Contributions |
The Plan provides a regular savings program for the employees of the Company under which participants may contribute 1% to 10% of their eligible compensation through pre-tax payroll deductions, subject to statutory limits. Participants direct their contributions into twenty-two various investment options offered by the Plan. The participants may change their investment decisions at any time by contacting the Vanguard Trust. However, any funds exchanged out of the Medtronic Interest Income Fund (which is included in the Medtronic, Inc. Master Trust Fund) must remain invested in another investment alternative for a period of at least three months before being moved to the Vanguard Total Bond Market Index Fund. Participants are also limited to two transfers per month in or out of the Medtronic Common Stock Fund (which is included in the Medtronic, Inc. Master Trust Fund). In addition, effective September 30, 2005, participants who exchange any amount out of a Vanguard mutual fund must wait 60 calendar days before exchanging any amounts back into the same fund. Participants receive Company matching contributions based on each participants contributions up to 6% of eligible compensation. Company matching contributions range from 50% to 75% of participant contributions, depending upon the achievement of certain Company performance goals. Participants direct the investment of their Company matching contributions into the same twenty-two investment options available for their elective contributions.
Additionally, contributions to the Retirement Plan account made by the Company equals 5% of the qualified participants eligible compensation, as defined in the Plan agreement. Participants may elect to invest their Retirement Plan account in any of the twenty-two investment options offered by the Plan.
7
Subject to prior discretionary approval of the Plan Administrator and subject to Plan provisions, a participant may contribute amounts to the Plan from another qualified plan (rollover contributions).
During the fiscal year ended April 30, 2006, a prohibited transaction occurred between the Plan and the Company in the form of a late deposit for $72,767 related to participant contributions under Section 1165 (a) of the Puerto Rico Internal Revenue Code. This late deposit related to plan year 2005 contributions. The deposit and lost interest income were subsequently contributed to the Plan during the fiscal year ended April 30, 2006.
|
Vesting and Forfeitures |
Participants are 100% vested in their contributions, including earnings and losses thereon, at all times. Active participants vest in the Company matching contributions, including earnings and losses thereon, at a rate of 20% per year and become fully vested in all Company matching contributions after five years of service. Participants also become fully vested upon normal retirement date, death, total disability, termination of the Plan or complete discontinuance of employer contributions. Employees are 100% vested in the Retirement Plan account contributions, which are made by the Company, at all times. Participant forfeitures of nonvested amounts may be used at the Plan Administrators election to reduce any reasonable administrative expenses of the Plan, reduce employer contributions, or make an additional matching contribution to active participants accounts. The balance of unallocated forfeited nonvested accounts as of April 30, 2007 and 2006 amounted to $22,000 and $17,000, respectively. Administrative expenses of $6,000 and $29,000, during fiscal years 2007 and 2006, respectively, were funded by forfeitures.
|
Distributions |
Active participants can request a partial or total withdrawal of their after-tax contributions account, rollover contributions account and the vested portion of their employer matching contributions account by giving prior notice to the Plan Administrator, with the exception that vested employer contributions are only distributed for a demonstrated financial need related to health, education, or welfare of the Participant or the Participants dependents.
Active participants may also take hardship withdrawals from their pre-tax contributions account if they incur immediate and severe financial needs that cannot be met through other available sources in the Plan, including available loan provisions. The amount of hardship withdrawal cannot exceed the amount of financial need.
Upon termination, retirement or upon incurring total disability, participants may receive distribution of their account in a lump sum payment, or, prior to January 1, 2006, an immediate annuity purchase from an insurance company or a combination of such methods of payment at the discretion of the participant.
|
Participant Loans |
Participants are limited to one outstanding loan and can borrow up to 50% of their vested account balance, not to exceed the maximum loan amount of $50,000. The minimum loan amount is $1,000. Loans are repaid through payroll deductions in equal amounts, typically over one to five years. The loans are collateralized by the balance in the participants account. The interest rate is the prime rate as received by Vanguard Trust from Reuters at the beginning of the month in which the proceeds of the loan are paid to the borrower and remains fixed for the duration of the loan. As of April 30, 2007, loans receivable were due at various dates through 2012, with interest rates ranging from 4.00% to 8.25%.
|
Plan Termination |
The Plan provides that the Board of Directors of Medtronic, Inc. can terminate the Plan. Although it has not expressed any intent to do so, the Company has the right under the Plan to discontinue its contributions at any time and to terminate the plan subject to the provisions of ERISA. In the event the Plan is terminated and there is not a successor plan, participants would become fully vested in their accounts. Benefits would be distributed at that time in accordance with the Plan provisions.
2. |
Summary of Significant Accounting Policies |
|
Basis of Accounting |
The accompanying financial statements are prepared on the accrual basis of accounting in accordance with accounting principles generally accepted in the United States of America (U.S. GAAP).
8
|
Use of Estimates |
The preparation of financial statements, in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates.
|
New Accounting Pronouncements |
In December 2005, the Financial Accounting Standards Board (FASB) issued FASB Staff Position AAG INV-1 and SOP 94-4-1, Reporting of Fully Benefit-Responsive Investment Contracts Held by Certain Investment Companies Subject to the AICPA Investment Company Guide and Defined-Contribution Health and Welfare and Pension Plans (the FSP). The FSP defined the circumstances in which an investment contract is considered fully benefit-responsive and provides certain reporting and disclosure requirements for fully benefit-responsive investment contracts in defined contribution, health and welfare, and pension plans. The financial statement presentation and disclosure provisions of the FSP are required to be applied retroactively to all prior periods presented for comparative purposes. The Plan adopted the provisions of the FSP as of April 30, 2007.
As described in the FSP, investment contracts held by a defined contribution plan are required to be reported at fair value. However, contract value is the relevant measurement attribute for that portion of the net assets available for benefits of a defined contribution plan attributable to fully benefit-responsive investment contracts because contract value is the amount participants would receive if they were to initiate permitted transactions under the terms of the plan. The Plan invests in fully benefit-responsive investment contracts through the Medtronic, Inc. Master Trust Fund. The Statement of Assets Available for Benefits presents the fair value of the investment contracts as well as the adjustment of the fully benefit-responsive investment contracts from fair value to contract value. The adjustment from fair value to contract value for the Plans interest in the Medtronic, Inc. Master Trust Fund relating to fully benefit-responsive investment contracts was $398,000 and $181,000 at April 30, 2007 and 2006, respectively. The Statement of Changes in Assets Available for Benefits is prepared on a contract value basis.
In September 2006, the FASB issued Statement of Financial Accounting Standards (SFAS) No. 157, Fair Value Measurements (SFAS No. 157). SFAS No. 157 establishes a framework for measuring fair value in accordance with generally accepted accounting principles, clarifies the definition of fair value within that framework, and expands disclosures about fair value measurements. SFAS No. 157 is effective, for the Plan, beginning the first quarter of fiscal year 2009. The Company does not believe that the adoption of SFAS No. 157 will have a material impact on the Plans financial statements.
|
Investment Valuation and Investment Income Recognition |
The Plans investments are stated at fair value, except for investment contracts held by the Medtronic Interest Income Fund, which are valued at contract value. Shares of mutual funds (registered investment companies) are valued at quoted market prices, which represent the net asset value of shares held by the Plan. The Plans interest in the Medtronic, Inc. Master Trust Fund, excluding the fully benefit-responsive investment contracts, is valued at its unit closing price (comprised of the aggregate fair value of the respective underlying investments plus any uninvested cash position). The Medtronic, Inc. Master Trust Fund investments include fully benefit-responsive investment contracts and common shares of the Company. The fully benefit-responsive investment contracts consist of both traditional guaranteed investment contracts (GICs) and synthetic investment contracts. The fair value of the traditional GICs are comprised of the expected future cash flows of each contract discounted to present value. The fair value of the synthetic investment contracts are comprised of the aggregate market values of the underlying investments in mutual funds and bond trusts. The common shares of Medtronic, Inc. held by the Medtronic Common Stock Fund are valued at their quoted market price. Participant loans receivable are valued at estimated fair value, consisting of outstanding principal and related unpaid interest.
Purchases and sales of investments are recorded on a trade-date basis. Interest income is accrued when earned. Dividend income is accrued on the ex-dividend date. Capital gain distributions are included in dividend income. The Plan presents in the Statements of Changes in Assets Available for Benefits the net appreciation (depreciation) in the fair value of its investments, which consists of realized gains and losses and the unrealized appreciation (depreciation) on those investments.
9
Investment Contracts
The Medtronic, Inc. Master Trust Fund, through its investment in the Medtronic Interest Income Fund, invests in fully benefit-responsive investment contracts including both traditional GIC contracts as well as synthetic GIC contracts. The Medtronic Interest Income Fund is credited with earnings from these contracts and charged for participant withdrawals and administrative expenses. The GIC issuer is contractually obligated to repay the principal and a specified interest rate that is guaranteed to the Plan. There are no reserves against contract value for credit risk of the contract issuer or otherwise. The crediting interest rate is based on a formula agreed upon with the issuer, but may not be less than 0%. Such interest rates are generally reviewed on a quarterly basis for resetting.
The terms of fully benefit responsive investment contracts generally provide for settlement of payments upon maturity of the contract, termination of the contract or total liquidation of the covered investments. However, fully benefit responsive contracts also provide guarantees from the issuers to redeem at contract value all bona fide employee benefit related payment requests made by the Plan, if Plan cash levels are insufficient to meet those requests. Generally, benefit payments requested by the Plan under this benefit responsive provision will be made pro-rata, based on the percentage of investments covered by each issuer.
A synthetic GIC is a wrap contract paired with an underlying investment or investments, usually a portfolio, owned by the Plan, of high-quality, intermediate term fixed income securities. The Plan purchases a wrapper contract from a financial services institution. A synthetic GIC credits a stated interest rate for a specified period of time. Investment gains and losses from the underlying investments in the synthetic GIC are amortized over the expected duration through the calculation of the interest rate applicable to the Plan on a prospective basis. The crediting rate is primarily based on the current yield-to-maturity of the covered investments, plus or minus amortization of the difference between the market value and contract value of the covered investments over the duration of the covered investments at the time of computation. The crediting rate is impacted by the change in the annual effective yield to maturity of the underlying securities, and is affected by the differential between the contract value and the market value of the covered investments. Depending on the change in duration from reset period to reset period, the magnitude of the impact to the crediting rate of the contract to market difference is heightened or lessened. The crediting rate is adjusted periodically usually either monthly or quarterly, but in no event is the crediting rate less than 0%.
Synthetic investment contracts generally impose conditions on both the Plan and the issuer. If an event of default occurs and is not cured, the non-defaulting party may terminate the contract. The following may cause the Plan to be in default: a breach of material obligation under the contract; a material misrepresentation; or a material amendment to the Plan agreement. The issuer may be in default if it breaches a material obligation under the investment contract; makes a material misrepresentation; has a decline in its long term credit rating below a threshold set forth in the contract; is acquired or reorganized and the successor issuer does not satisfy the investment or credit guidelines applicable to issuers. If, in the event of default of an issuer, the Plan were unable to obtain a replacement investment contract, withdrawing plans may experience losses if the value of the Plans assets no longer covered by the contract are below contract value. The Plan may seek to add additional issuers over time to diversify the Plans exposure to such risk, but there is no assurance the Plan may be able to do so. The combination of the default of an issuer and an inability to obtain a replacement agreement could render the Plan unable to achieve its objective of maintaining a stable contract value.
Contract termination occurs whenever the contract value or market value of the covered investments reaches zero or upon certain events of default. If the contract terminates due to issuer default (other than a default occurring because of a decline in its rating), the issuer will generally be required to pay to the Plan the excess, if any, of contract value over market value on the date of termination. If a synthetic GIC terminates due to a decline in the ratings of the issuer, the issuer may be required to pay to the Plan the cost of acquiring a replacement contract (i.e. replacement cost) within the meaning of the contract. If the contract terminates when the market value equals zero, the issuer will pay the excess of contract value over market value to the Plan to the extent necessary for the Plan to satisfy outstanding contract value withdrawal requests. Contract termination also may occur by either party upon election and notice.
Certain events limit the ability of the Plan to transact at contract value with the insurance company and the financial institution issuer. Such events include the following: (i) amendments to the Plan documents (including complete or partial plan termination or merger with another plan); (ii) changes to the Plans prohibition on competing investment options or deletion of equity wash provisions; (iii) bankruptcy of the Plan sponsor or other Plan sponsor events (e.g. divestitures or spin-offs of a subsidiary) which cause a significant withdrawal from the Plan or (iv) the failure of the trust to qualify for exemption from federal income taxes or any required prohibited transaction exemption under ERISA. The Plan Administrator does not believe that the occurrence of any such value event, which would limit the Plans ability to transact at contract value with participants, is probable.
10
Because traditional GICs and synthetic GICs are fully benefit-responsive, contract value is the relevant measurement attribute for that portion of the net assets available for benefits. Contract value represents contributions made under the contract, plus earnings, less participant withdrawals and administrative expenses. Participants may ordinarily direct the withdrawal or transfer of all or a portion of their investment at contract value.
|
Fiscal Year | ||
Average yields for GICs and Synthetic GICs: |
2007 |
|
2006 |
Based on actual earnings |
4.7% |
|
4.4% |
Based on interest rate credited to participants |
4.6% |
|
4.3% |
Administrative Expenses
Plan expenses, excluding participant loan fees, are paid for by the Plan. Forfeitures may be used to pay such expenses. Plan expenses may also be paid for by the Company. Participants with loans pay an origination and annual loan fee for loan administration and maintenance from their respective Plan accounts.
Payment of Benefits
Benefit payments are recorded upon distribution.
Risks and Uncertainties
The Plan provides for various investment options representing varied combinations of stocks, including Medtronic, Inc. common stock, bonds, fixed income securities, mutual funds and other investment securities. Investment securities are exposed to various risks, such as interest rate, market and credit risks. Due to the level of risk and uncertainty, it is reasonably possible that changes in risks could materially affect participants account balances and the amounts reported in the Statements of Assets Available for Benefits and the Statements of Changes in Assets Available for Benefits.
Concentration of Market Risk
As of April 30, 2007 and 2006, approximately 5% and 12%, respectively, of the Plans assets were invested in the common stock of Medtronic, Inc. The underlying value of the Medtronic Common Stock Fund, which is part of the Medtronic, Inc. Master Trust Fund, is entirely dependent on the performance of Medtronic, Inc. and the markets evaluation of such performance. It is reasonably possible that changes in the fair value of Medtronic, Inc. common stock could materially affect participants account balances and the amounts reported in the Statement of Assets Available for Benefits and the Statement of Changes in Assets Available for Benefits.
3. |
Plans Interest in the Medtronic, Inc. Master Trust Fund |
Certain assets of the Plan are invested in the Medtronic, Inc. Master Trust Fund which also includes certain assets of the Medtronic, Inc. Savings and Investment Plan. The Plans Recordkeeper maintains a separate account for the associated Plan assets and liabilities held within the Medtronic, Inc. Master Trust Fund. At April 30, 2007 and 2006, the Plans interest in the net assets of the Medtronic, Inc. Master Trust Fund was 1.7% and 0.6%, respectively.
The Medtronic, Inc. Master Trust Fund is invested in three funds the Medtronic Common Stock Fund, the Medtronic ESOP Fund, and the Medtronic Interest Income Fund. The Medtronic Common Stock Fund and Medtronic ESOP Fund are both fully invested in Medtronic, Inc. common stock. The investments in the Medtronic Interest Income Fund consist of guaranteed investment contracts issued by financial institutions, synthetic investment contracts issued by financial institutions which are backed by investment-grade, fixed-income securities and bond mutual funds, and money market securities.
Interfund transfers within the master trust generally relate to transfers initiated by participants of their account balances either into Plan investment options which are part of the Medtronic, Inc. Master Trust Fund or into other Plan investment options which are not part of the Medtronic, Inc. Master Trust Fund.
11
The financial data of the Medtronic, Inc. Master Trust Fund is as follows:
Medtronic, Inc. Master Trust Fund
Statements of Master Trust Assets
(in 000s)
|
|
April 30, |
| ||||
|
|
2007 |
|
2006 |
| ||
|
|
|
|
|
|
|
|
Investments at fair value: |
|
|
|
|
|
|
|
Medtronic, Inc. common stock |
|
$ |
1,102,213 |
|
$ |
1,150,145 |
|
Guaranteed investment contracts |
|
|
287,972 |
|
|
242,134 |
|
Medtronic, Inc. Master Trust Fund assets, at fair value |
|
|
1,390,185 |
|
|
1,392,279 |
|
Adjustment from fair value to contract value relating to fully-benefit responsive investment contracts |
|
|
5,281 |
|
|
6,858 |
|
Medtronic, Inc. Master Trust Fund assets |
|
$ |
1,395,466 |
|
$ |
1,399,137 |
|
Medtronic, Inc. Master Trust Fund
Statements of Changes in Master Trust Assets
(in 000s)
|
|
Years Ended April 30, |
| ||||
|
|
2007 |
|
2006 |
| ||
Additions: |
|
|
|
|
|
|
|
Investment income: |
|
|
|
|
|
|
|
Interest |
|
$ |
11,696 |
|
$ |
10,546 |
|
Dividends on Medtronic, Inc. common stock |
|
|
9,702 |
|
|
8,854 |
|
Net appreciation (depreciation) in fair value of investments |
|
|
62,895 |
|
|
(51,956 |
) |
Total investment income (loss) |
|
|
84,293 |
|
|
(32,556 |
) |
Administrative expenses |
|
|
(214 |
) |
|
(955 |
) |
Total income (loss) |
|
|
84,079 |
|
|
(33,511 |
) |
Employer contributions |
|
|
23,767 |
|
|
26,978 |
|
Interfund transfers, net |
|
|
(111,517 |
) |
|
(88,075 |
) |
Net decrease |
|
|
(3,671 |
) |
|
(94,608 |
) |
Medtronic, Inc. Master Trust Fund assets |
|
|
|
|
|
|
|
Beginning of year |
|
|
1,399,137 |
|
|
1,493,745 |
|
End of year |
|
$ |
1,395,466 |
|
$ |
1,399,137 |
|
The net appreciation (depreciation) in the fair value of the Medtronic, Inc. Master Trust Fund investments for fiscal years 2007 and 2006, including gains and losses on investments purchased and sold as well as unrealized gains and losses on those held during the year, was $62,895 and $(51,956), respectively, and relates to investments in Medtronic, Inc. common stock only.
12
The Plans interest in the total assets held in the Medtronic, Inc. Master Trust Fund and changes in assets during the period are as follows (in 000s):
|
|
Years Ended April 30, |
| ||||
|
|
2007 |
|
2006 |
| ||
Plans interest in the Medtronic, Inc. Master Trust Fund, beginning of year |
|
$ |
7,939 |
|
$ |
7,768 |
|
|
|
|
|
|
|
|
|
Investment income: |
|
|
|
|
|
|
|
Interest income |
|
|
881 |
|
|
252 |
|
Dividends on Medtronic, Inc. common stock |
|
|
16 |
|
|
14 |
|
Net appreciation (depreciation) in fair value of investments |
|
|
95 |
|
|
(104 |
) |
Total investment income |
|
|
992 |
|
|
162 |
|
Administrative expenses |
|
|
(13 |
) |
|
(32 |
) |
Total income |
|
|
979 |
|
|
130 |
|
|
|
|
|
|
|
|
|
Employer contributions |
|
|
3,197 |
|
|
287 |
|
Interfund transfers, net |
|
|
11,495 |
|
|
(65 |
) |
Current year adjustment from contract value to fair value for Plans interest in the Medtronic, Inc. Master Trust Fund relating to fully benefit-responsive investment contracts |
|
|
(398 |
) |
|
(181 |
) |
Prior year adjustment from contract value to fair value for Plans interest in the Medtronic, Inc. Master Trust Fund relating to fully benefit-responsive investment contracts |
|
|
181 |
|
|
|
|
Plans interest in the Medtronic, Inc. Master Trust Fund, end of year |
|
$ |
23,393 |
|
$ |
7,939 |
|
4. |
Investments |
Individual investments representing 5 percent or more of the Plans assets are as follows (in 000s):
|
|
April 30, |
| ||||
|
|
2007 |
|
2006 |
| ||
Plans interest in Medtronic, Inc. Master Trust Fund |
|
$ |
23,393 |
|
$ |
7,939 |
|
|
|
|
|
|
|
|
|
Mutual funds: |
|
|
|
|
|
|
|
Vanguard 500 Index Fund |
|
|
2,760 |
|
|
2,430 |
|
Vanguard Wellington Fund |
|
|
2,382 |
|
|
1,515 |
|
The net appreciation in the fair value of mutual funds during fiscal years 2007 and 2006, including gains and losses on mutual funds purchased and sold as well as unrealized gains and losses on those held during the year, was $688,000 and $537,000, respectively.
5. |
Related Party Transactions |
The Plans investments consist of the Plans interest in Medtronic, Inc. Master Trust and shares of mutual funds managed by the Plans Trustee, as well as participant loans receivable. All investment transactions are managed by the Trustee and qualify as party-in-interest transactions, which are exempt from the prohibited transactions rules. These transactions are allowed by the Plan and the Internal Revenue Code. In addition, as noted previously, the Medtronic, Inc. Master Trust Fund invests in the common stock of the Parent Company.
13
During the years ended April 30, 2007 and April 30, 2006, the Plan had transactions with Vanguard Trust, the Plans Recordkeeper, which are allowed by the Plan and the Internal Revenue Code. These transactions qualify as party-in-interest transactions, which are exempt from the prohibited transactions rules.
Total purchases of Plan investments with parties-in-interest for the years ended April 30, 2007 and 2006 were $12,335,000 and $3,837,000, respectively, and proceeds from sales of Plan investments with parties-in-interest were $7,410,000 and $2,078,000, respectively.
6. |
Reconciliation of Financial Statements to Form 5500 |
Fully benefit-responsive GICs are recorded on the Form 5500 at contract value while in the Plans financial statements these investments are presented at fair value with an adjustment to contract value.
7. |
Tax Status |
The Plan received a favorable determination letter from the Puerto Rico Treasury Department on May 23, 2001. The Puerto Rico Treasury Department has determined that the Plan and the related trust are designed in accordance with Section 1165 (a) of the Puerto Rico Internal Revenue Code of 1994 and are, therefore, exempt from Puerto Rico income taxes. The Plan has been amended since receiving the determination letter. However, the Plan Administrator believes that the Plan is currently designed and being operated in compliance with the applicable requirements of the Puerto Rico Internal Revenue Code. Therefore, no provision for income taxes has been included in the Plans financial statements.
14
SUPPLEMENTAL SCHEDULE
The Medtronic Puerto Rico Employees Savings and Investment Plan
Schedule H, Line 4i Schedule of Assets (Held at End of Year)
April 30, 2007
(in 000s)
(a) |
|
(b) |
|
(c) |
|
(d) |
|
(e) | |
|
|
Identity of Issue, Borrower, Lessor |
|
Description of Investment, Including Maturity Date, Rate of Interest, Collateral, Par or Maturity Value |
|
Cost |
|
Current Value | |
|
|
|
|
|
|
|
|
|
|
* |
|
Vanguard 500 Index Fund |
|
Registered Investment Company |
|
** |
|
$ |
2,760 |
* |
|
Vanguard Wellington Fund |
|
Registered Investment Company |
|
** |
|
|
2,382 |
* |
|
Vanguard Total Bond Market Index Fund |
|
Registered Investment Company |
|
** |
|
|
1,075 |
* |
|
Vanguard Target Retirement 2020 Fund |
|
Registered Investment Company |
|
** |
|
|
887 |
* |
|
Vanguard Target Retirement 2025 Fund |
|
Registered Investment Company |
|
** |
|
|
732 |
* |
|
Vanguard International Growth Fund |
|
Registered Investment Company |
|
** |
|
|
470 |
* |
|
Vanguard PRIMECAP Fund |
|
Registered Investment Company |
|
** |
|
|
421 |
* |
|
Vanguard Explorer Fund |
|
Registered Investment Company |
|
** |
|
|
393 |
* |
|
Vanguard Windsor II Fund |
|
Registered Investment Company |
|
** |
|
|
391 |
* |
|
Vanguard Extended Market Index Fund |
|
Registered Investment Company |
|
** |
|
|
367 |
* |
|
Vanguard Target Retirement 2010 Fund |
|
Registered Investment Company |
|
** |
|
|
306 |
* |
|
Vanguard Target Retirement 2015 Fund |
|
Registered Investment Company |
|
** |
|
|
244 |
* |
|
Vanguard Target Retirement 2035 Fund |
|
Registered Investment Company |
|
** |
|
|
217 |
* |
|
Vanguard Target Retirement 2030 Fund |
|
Registered Investment Company |
|
** |
|
|
207 |
* |
|
Vanguard Target Retirement 2040 Fund |
|
Registered Investment Company |
|
** |
|
|
164 |
* |
|
Vanguard U.S. Growth Fund |
|
Registered Investment Company |
|
** |
|
|
88 |
* |
|
Vanguard Target Retirement 2045 Fund |
|
Registered Investment Company |
|
** |
|
|
13 |
* |
|
Vanguard Target Retirement 2050 Fund |
|
Registered Investment Company |
|
** |
|
|
2 |
* |
|
Participant loans |
|
Interest at 4.00%-8.25% due at various dates through 2012 |
|
** |
|
|
1,183 |
|
|
|
|
|
|
|
|
|
|
|
|
Total Plan investments, excluding the Plans interest in the Medtronic, Inc. Master Trust Fund |
|
|
|
|
|
|
12,302 |
|
|
|
|
|
|
|
|
|
|
|
|
Plans interest in Medtronic, Inc. Master Trust Fund |
|
|
|
|
|
|
23,393 |
|
|
|
|
|
|
|
|
$ |
35,695 |
* |
Denotes party-in-interest. |
** Cost information is excluded as it is no longer required for participant-directed investments.
15